Filing Details
- Accession Number:
- 0001104659-18-014162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-01 18:00:41
- Reporting Period:
- 2018-02-27
- Accepted Time:
- 2018-03-01 18:00:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640266 | Voyager Therapeutics Inc. | VYGR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711043 | Ph.d. Dinah Sah | C/O Voyager Therapeutics 75 Sidney Street Cambridge MA 02139 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-27 | 2,184 | $7.27 | 140,872 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-27 | 4,376 | $8.33 | 145,248 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-27 | 5,000 | $11.09 | 150,248 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-27 | 4,063 | $11.83 | 154,311 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-27 | 15,623 | $30.00 | 138,688 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-27 | 2,184 | $0.00 | 2,184 | $7.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-27 | 4,376 | $0.00 | 4,376 | $8.33 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-27 | 5,000 | $0.00 | 5,000 | $11.09 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-27 | 4,063 | $0.00 | 4,063 | $11.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,957 | 2025-04-25 | No | 4 | M | Direct | |
| 28,570 | 2025-08-25 | No | 4 | M | Direct | |
| 35,000 | 2026-02-01 | No | 4 | M | Direct | |
| 60,937 | 2027-02-08 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of January 1, 2015, and 1/48th of the shares underlying such option vesting monthly thereafter.
- The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of August 1, 2015, and 1/48th of the shares underlying such option vesting monthly thereafter. This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3.
- The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of February 1, 2016, and 1/48th of the shares underlying such option vesting monthly thereafter. This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3.
- The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of February 8, 2017, and 1/48th of the shares underlying such option vesting monthly thereafter. This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3.
Billionaire Hedge Funds
